NEW ZEALAND MEDICAL JOURNAL最新文献_第3页

"Levelling up" the gender pay gap for Asian women academics in medicine and health sciences. 医学和健康科学领域亚洲女性学者的性别薪酬差距“拉平”。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-06-27 DOI: 10.26635/6965.6997

Lillian Ng, Emma Sadera, Roshini Peiris-John, Stuti L Misra, Joanna Ting-Wai Chu, Ashwini Datt, Rachel Simon-Kumar

{"title":"\"Levelling up\" the gender pay gap for Asian women academics in medicine and health sciences.","authors":"Lillian Ng, Emma Sadera, Roshini Peiris-John, Stuti L Misra, Joanna Ting-Wai Chu, Ashwini Datt, Rachel Simon-Kumar","doi":"10.26635/6965.6997","DOIUrl":"10.26635/6965.6997","url":null,"abstract":"The gender pay gap for academic women of Asian ethnicity at Aotearoa New Zealand's largest university is 33.5%. The aim of this viewpoint is to raise consciousness, educate and contribute to dialogue on concerns relating to Asian women advancing in academia, particularly in medicine and health sciences. We invite collective participation in efforts at departmental, faculty and institutional levels to better identify and dismantle discrimination and increase the representation of Asian women in academic medicine. We endorse concepts of accountability, transparency and strengthening institutional frameworks to \"level up\" intersectional pay gaps by recommending three actions: 1) ensuring accountability by mandatory training, monitoring and reporting on gender pay equity, diversity and conscious inclusion, 2) creating transparency in salary, pay rates, hiring, tenure and promotions, and 3) convening a task force at each faculty with specific mentorship and leadership initiatives for women of colour. We emphasise that \"levelling up\" requires a collective will to act. We ask our colleagues and the academy to scrutinise attitudes and biases towards ethnic minority women in hiring, tenure and promotion processes. We advocate for enacting policy so those who experience inequity can see change. When rendered, it will be a legacy to the next generation of ethnic minority women entering the academy, and potentially other marginalised groups as well.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"138 1617","pages":"113-120"},"PeriodicalIF":1.2,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144508874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Erratum. 勘误表。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-06-27 DOI: 10.26635/6965.er1617

引用次数: 0

Pembrolizumab-related toxicity in patients with advanced melanoma. 晚期黑色素瘤患者的派姆单抗相关毒性。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-06-27 DOI: 10.26635/6965.6777

Florence de Roo, Amritpreet Singh, Eric Zheng, Alvin Tan, Annie N M Wong

{"title":"Pembrolizumab-related toxicity in patients with advanced melanoma.","authors":"Florence de Roo, Amritpreet Singh, Eric Zheng, Alvin Tan, Annie N M Wong","doi":"10.26635/6965.6777","DOIUrl":"10.26635/6965.6777","url":null,"abstract":"Aim: Pembrolizumab has revolutionised the treatment of melanoma. Immune checkpoint inhibitors (ICI) are well tolerated in trials, but the real-world incidence of toxicities and their management are not well described. We investigated the incidence and management of toxicities in New Zealand.Methods: A retrospective review was conducted on patients with metastatic melanoma treated with pembrolizumab at Wellington and Waikato Hospitals between March 2016 and September 2021. The occurrence, severity and management of toxicities was recorded.Results: Of the 273 patients, 42% experienced treatment-related toxicity. Seventy-five percent of toxicities were grade 1/2 (mild), 25% grade 3/4 (moderate or life-threatening) and <1% grade 5 (fatal). Per organ system, 28% were dermatological, 18% gastrointestinal, 14% endocrine, 9% musculoskeletal, 5% respiratory, 5% renal and <1% haematological, cardiac or neurological. Thirteen percent of patients were hospitalised and 21% had pembrolizumab stopped due to toxicity. There were 45 referrals to subspecialty services.Conclusion: Pembrolizumab-related toxicities are common and mostly mild but can require protracted courses of steroids and specialty referrals. Prospective data on toxicity and the management of toxicities from ICIs are needed.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"138 1617","pages":"62-75"},"PeriodicalIF":1.2,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144508881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clustering of community-acquired pneumonia in hospitalised adults in the Christchurch Region: association with socio-economic deprivation. 克赖斯特彻奇地区住院成人社区获得性肺炎的聚集性：与社会经济剥夺的关系

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-06-27 DOI: 10.26635/6965.6905

Nicole Crequer, Cate McCall, Anna Swanson, Emma Vlasiuk, Stephen T Chambers, Anitra C Carr

{"title":"Clustering of community-acquired pneumonia in hospitalised adults in the Christchurch Region: association with socio-economic deprivation.","authors":"Nicole Crequer, Cate McCall, Anna Swanson, Emma Vlasiuk, Stephen T Chambers, Anitra C Carr","doi":"10.26635/6965.6905","DOIUrl":"10.26635/6965.6905","url":null,"abstract":"Aim: Community-acquired pneumonia (CAP) is inequitably experienced in populations globally, with multiple social and environmental factors contributing to the risk of CAP; thus, predicting communities at increased risk is difficult. The aims of this study were to determine the geographical distribution of adults with CAP requiring hospitalisation in Christchurch, and to examine the associations between CAP and socio-economic and area deprivation.Methods: A retrospective clinical records review was conducted of all adult patients hospitalised with CAP at Christchurch Hospital over a 12-month period. Geocoding residential addresses allowed for geospatial hotspot analysis using the Getis-Ord Gi* method. Comparison of the relative rates of CAP in different socio-economic deprivation deciles was assessed using New Zealand census data and the Index of Multiple Deprivation (IMD).Results: The dataset comprised 924 hospitalisations. CAP hotspots were located in the northeast and southwest of the city. CAP was not equally distributed across the deprivation quantiles (p <0.001); compared with the least deprived quintile, quintiles four and five had rate ratios (95% confidence interval [CI]) of 1.5 (1.3 to 1.8) and 1.6 (1.3 to 2.0), respectively. Patients with CAP who identified as Māori or Pacific peoples were significantly younger, and a higher proportion were resident in areas of highest socio-economic deprivation relative to patients who identified as NZ European.Conclusion: This study identified hotspots within Christchurch with higher rates of CAP requiring hospitalisation and has contributed further New Zealand-based evidence on the influence of socio-economic disparities on health inequity.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"138 1617","pages":"85-99"},"PeriodicalIF":1.2,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144508876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Aotearoa New Zealand cochlear implant programmes equity audit: addressing disparities and equity for Māori with severe and profound hearing loss. 新西兰Aotearoa人工耳蜗植入方案公平审计：解决严重和深度听力损失Māori患者的差异和公平问题。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-06-27 DOI: 10.26635/6965.6807

Pat Tuohy, Neil Heslop, Jill Mustard, Phil Bird, Holly Teagle, Robert Gunn

{"title":"Aotearoa New Zealand cochlear implant programmes equity audit: addressing disparities and equity for Māori with severe and profound hearing loss.","authors":"Pat Tuohy, Neil Heslop, Jill Mustard, Phil Bird, Holly Teagle, Robert Gunn","doi":"10.26635/6965.6807","DOIUrl":"10.26635/6965.6807","url":null,"abstract":"Aim: We examined equity in the provision of cochlear implant services for New Zealand Māori compared with other New Zealanders.Methods: The client databases of both Aotearoa New Zealand cochlear implant programmes were searched and an anonymised dataset was provided to the audit team. Ethics committee approval was not required. Ethnicity was categorised as Māori or non-Māori.Results: There is no significant difference between Māori and non-Māori with respect to acceptance for surgery rates and time from acceptance to surgery. Māori children and adults have a higher rate of proceeding to surgery than non-Māori ethnic groups. Average days to surgery for adult clients reduced over the period studied. Time to surgery was low for both child ethnic groups. When a measure of prioritisation (clinical priority access criteria [CPAC]) was incorporated into the evaluation, we found that Māori clients waited slightly, but not significantly less time per unit of CPAC scored.Conclusion: We were able to demonstrate that once Māori clients accessed the cochlear implant programmes, they were implanted at a similar rate as non-Māori, and adult clients experienced equivalent waiting times even when adjusted for CPAC score. These favourable results suggest that our internal systems and pathways are promoting equity.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"138 1617","pages":"50-61"},"PeriodicalIF":1.2,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144508875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Infrastructure is not a cure: Aotearoa New Zealand's health crisis demands vision, not just buildings. 基础设施并不能解决问题：新西兰的健康危机需要远见，而不仅仅是建筑。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-06-06 DOI: 10.26635/6965.e1616

Frank Frizelle

引用次数: 0

Endoscopic full-thickness resection using full-thickness resection device for treatment of upper and lower gastrointestinal tract lesions-the first New Zealand study. 内镜下全层切除采用全层切除装置治疗上、下消化道病变-新西兰首例研究。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-06-06 DOI: 10.26635/6965.6893

Sharon Wing-Kee Yiu, Erin Horsfall, Ravinder Ogra, Cameron Schauer, Anurag Sekra

{"title":"Endoscopic full-thickness resection using full-thickness resection device for treatment of upper and lower gastrointestinal tract lesions-the first New Zealand study.","authors":"Sharon Wing-Kee Yiu, Erin Horsfall, Ravinder Ogra, Cameron Schauer, Anurag Sekra","doi":"10.26635/6965.6893","DOIUrl":"10.26635/6965.6893","url":null,"abstract":"Aim: The full-thickness resection device (FTRD) offers an innovative treatment approach for lesions unsuitable for traditional endoscopic resection. This study evaluates FTRD's safety and efficacy for resection of upper and lower gastrointestinal tract lesions in New Zealand, where data are currently lacking.Method: This multicentre retrospective study included patients who underwent FTRD at Middlemore Hospital and North Shore Hospital between 1 January 2017 and 30 April 2023. Histology and post-procedural complications up to 30 days were collated. Ethics approval and locality assessment were granted.Results: A total of 51 patients-18 males (35%) and 33 (65%) females-with a mean age of 63.5 years were included. Five lesions were upper gastrointestinal (four gastric body; one duodenal) and 46 were colonic cases (20 appendiceal orifice lesions; five caecal; four from hepatic flexure; two each at sigmoid, ascending and transverse colon; one descending colon and 10 from the rectum). Technically successful FTRD deployment was achieved in 86% (n=44), with negative histological margins (R0 resection) seen in 82% (n=31). Thirteen patients were excluded from this calculation, as histological clearance was not applicable. Procedure-related complications occurred in 12% (n=6): there were three appendicitis cases; one experienced delayed bleeding requiring blood transfusion and endoscopic management; and two experienced technical complications (one snare entrapment and one clip entrapment).Conclusion: This study demonstrates our experience with FTRD in New Zealand with technical success and R0 resection rates similar to the published literature. There is a considerable adverse event rate that requires careful patient discussion and consent prior to selection of this procedure.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"138 1616","pages":"43-49"},"PeriodicalIF":1.2,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144235603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Mental health and wellbeing of ethnic migrant women and girls in Aotearoa New Zealand: a scoping review. 新西兰奥特罗阿族裔移民妇女和女孩的心理健康和福祉：范围审查。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-06-06 DOI: 10.26635/6965.6936

Julia Vajda De Albuquerque, Roshini Peiris-John, Parvinca Saini, Sarah Hetrick, Rodrigo Ramalho, Isabelle Uy, Vartika Sharma

{"title":"Mental health and wellbeing of ethnic migrant women and girls in Aotearoa New Zealand: a scoping review.","authors":"Julia Vajda De Albuquerque, Roshini Peiris-John, Parvinca Saini, Sarah Hetrick, Rodrigo Ramalho, Isabelle Uy, Vartika Sharma","doi":"10.26635/6965.6936","DOIUrl":"10.26635/6965.6936","url":null,"abstract":"Aim: To identify and synthesise the literature on mental health and wellbeing of Asian and MELAA (Middle Eastern, Latin American and African) women and girls in Aotearoa New Zealand (New Zealand).Methods: We searched American Psychological Association (APA) PsycInfo, CINAHL, Embase (Ovid) and MEDLINE (Ovid) for studies published in English up to July 2023 investigating the mental health and wellbeing of Asian and MELAA women and girls living in New Zealand. Studies including other participants were eligible if they provided disaggregated data for Asian and MELAA women/girls in New Zealand. We extracted data on study characteristics and all relevant findings related to their mental wellbeing.Results: Twenty-four studies provided data on approximately 15,000 Asian and MELAA women and girls aged over 12 years. The studies had heterogeneous population groups and outcomes. Three exclusively focussed on Asian women. Most studies (n=17) did not provide disaggregated data for Asian and MELAA women and girls in relation to all relevant outcomes reported. Investigated outcomes included prevalence data and symptoms of mental health conditions and mental wellbeing (n=18) and associations of socio-demographic factors with mental health (n=9).Conclusion: The limited peer-reviewed data underpin the lack of evidence-based policy planning. Future research focussed on Asian and MELAA women and girls is needed to enhance their wellbeing and achieve equitable health outcomes.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"138 1616","pages":"69-98"},"PeriodicalIF":1.2,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144235606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Blunt cerebrovascular injury in trauma patients: an under-recognised injury pattern at Auckland City Hospital. 创伤患者的钝性脑血管损伤：奥克兰市医院一种未被认识的损伤模式。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-06-06 DOI: 10.26635/6965.6903

Rebecca Schroll, Samuel A Flint, Donald Harris, Ian Civil

{"title":"Blunt cerebrovascular injury in trauma patients: an under-recognised injury pattern at Auckland City Hospital.","authors":"Rebecca Schroll, Samuel A Flint, Donald Harris, Ian Civil","doi":"10.26635/6965.6903","DOIUrl":"10.26635/6965.6903","url":null,"abstract":"Aim: Blunt cerebrovascular injury (BCVI) is a rare but potentially devastating injury that can lead to stroke and death without early diagnosis and treatment. Evidence-based practice guidelines recommend screening at-risk patients with neck computed tomographic angiography (CTA). We sought to evaluate the efficacy of such a screening protocol at a high-volume trauma centre in Aotearoa New Zealand.Methods: A retrospective chart review was conducted of adult blunt trauma patients who presented to our trauma centre from March to August 2023 who had injuries that met criteria for screening. Adherence to protocol as determined by capture of neck CTA within 6 hours of admission, incidence of BCVI, stroke and death were collected.Results: Ninety-five patients met criteria to screen for BCVI; only 41 (43%) underwent screening CTA. BCVI incidence was 6/41 (14.6%). Of the 54 patients not screened, there was one BCVI that progressed to stroke. Overall BCVI rate is estimated at 2.4%; an additional seven BCVIs may have been present.Conclusion: BCVI is more common than previously recognised in blunt trauma patients. Increased awareness of BCVI screening protocols and systematic screening systems to facilitate early identification and treatment should be implemented to diminish the incidence of missed injury and devastating sequela.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"138 1616","pages":"59-68"},"PeriodicalIF":1.2,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144235601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinician feedback for bi-annual quality improvement reports generated by the Prostate Cancer Outcomes Registry Australia and New Zealand. 临床医生对由澳大利亚和新西兰前列腺癌结局登记处生成的两年一次的质量改进报告的反馈。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2025-06-06 DOI: 10.26635/6965.6721

Andreas S Nicolaou, Eng Ann Toh, Judith Clarke, Stephen Mark, Phil Hider

{"title":"Clinician feedback for bi-annual quality improvement reports generated by the Prostate Cancer Outcomes Registry Australia and New Zealand.","authors":"Andreas S Nicolaou, Eng Ann Toh, Judith Clarke, Stephen Mark, Phil Hider","doi":"10.26635/6965.6721","DOIUrl":"10.26635/6965.6721","url":null,"abstract":"Aim: This study aims to 1) assess clinician perspectives on methods of report distribution, 2) assess the clinical value and utility of the Prostate Cancer Outcomes Registry (PCOR) Quality Indicator (QI) reports for New Zealand urologists, and 3) identify barriers impacting engagement with these reports.Methods: PCOR-ANZ provides 6-monthly QI reports to participating clinicians and hospitals. New Zealand urologists receiving scheduled reports were surveyed digitally. Interviews were conducted for qualitative feedback.Results: Thirty-three of 49 (67%) eligible urologists participated in this study. One hundred percent (n=33) of clinicians received notifications for new QI reports, 42% (n=14) finding them too lengthy. Seventy-six percent (n=25) and 70% (n=23) found the reports valuable for auditing and improving their practice, respectively.Conclusion: Report distribution and data presentation are effective. PDFs are preferred by clinicians, but proposed interactive mediums were received positively. Reports are valued for auditing and improving practice. Report length and clinician time constraints are key barriers affecting engagement. A revision of the items included in QI reports would be beneficial to reflect modern practice. There is demand for a pathway to allow clinicians to contact others for peer review and advice.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"138 1616","pages":"13-19"},"PeriodicalIF":1.2,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144235602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0